Autism Research Database - Principal Investigator Project Details

Project Element	Element Description
Project Title Project Title	EU-AIMS
Principal Investigator Principal Investigator	No PI Listed
Description Description	The project, which will take place over the next five years, brings together top scientists from universities around the world, experts from Autism Speaks – the world’s leading autism science and advocacy organization – as well as major global drug companies from the European Federation of Pharmaceutical Industry Associations (EFPIA) including Roche, Eli Lilly, Servier, Janssen Pharmaceutica, Pfizer and Vifor Pharma.
Funder Funder	Autism Speaks
Funding Country Funding Country	United States
Fiscal Year Funding Fiscal Year Funding	114605
Current Award Period Current Award Period	2012-2017
Strategic Plan Question Strategic Plan Question	Question 7: How Do We Continue to Build, Expand, and Enhance the Infrastructure System to Meet the Needs of the ASD Community?
Funder’s Project Link Funder’s Project Link	No URL available.
Institution Institution	King's College London
Institute Location Institute Location	United Kingdom
Project Number Project Number	9215
Government or Private Government or Private	Private
History/Related Projects History/Related Projects	EU-AIMS \| 130188 \| 2013 \| 9215 EU-AIMS \| 104519 \| 2015 \| 9215 EU-AIMS \| 130690 \| 2014 \| 9215 EU-AIMS \| 0 \| 2017 \| 9215